The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 01, 2015
- Source ID
- 10.1016/j.bbmt.2015.03.017
Entities
People
- Andrew S. Artz
- Christopher C. Dvorak
- Christopher N. Bredeson
- Frédéric Baron
- George B. Selby
- Görgün Akpek
- Hillard M Lazarus
- Jennifer L. Holter-chakrabarty
- Kenneth R. Cooke
- Kirsten M. Williams
- Mahmoud Aljurf
- Marcelo C Pasquini
- Mei-jie Zhang
- Namali Pierson
- Philip L. Mccarthy
- Richard F. Olsson
- Robert B. Epstein
- Xiaochun Zhu
Organizations
- Actinium Pharmaceuticals (United States)
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- GSK
- Health Research
- Health Resources and Services Administration
- HistoGenetics (United States)
- Incyte
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- Miltenyi Biotec
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- Office of Naval Research
- Onyx Pharmaceuticals
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- St. Baldrick's Foundation
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)
- University of Minnesota
- University of Utah